Overview Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This presentation will discuss the pathophysiology, disease progression, and the physical & emotional burden of autosomal dominant polycystic kidney disease (ADPKD).
- About
- Events
- Resource Center
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Featured Events
Events
Biomarkers In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
In this cutting-edge webinar, we will discuss the most current data on biomarkers in ADPKD, focusing on those that are most validated in the literature.
Biomarkers In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
In this cutting-edge webinar, we will discuss the most current data on biomarkers in ADPKD, focusing on those that are most validated in the literature.
Factors Influencing Drug Dialyzability
In this webinar, we will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.
Factors Influencing Drug Dialyzability
In this webinar, we will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.
Diagnostic Imaging & TKV: A Discussion On Breaking Barriers
For the first time on NephU we are bringing together a Nephrologist and Radiologist to discuss breaking down barriers encountered with TKV orders.
Diagnostic Imaging & TKV: A Discussion On Breaking Barriers
For the first time on NephU we are bringing together a Nephrologist and Radiologist to discuss breaking down barriers encountered with TKV orders.
Hyperuricemia In CKD & Specific Considerations In ADPKD
This webinar will cover biochemistry and physiology of uric acid and its pathway. We will discuss the pathophysiology of uric acid in gout, CKD, and ADPKD. We will also discuss therapeutic options and the current controversies around them.
Hyperuricemia In CKD & Specific Considerations In ADPKD
This webinar will cover biochemistry and physiology of uric acid and its pathway. We will discuss the pathophysiology of uric acid in gout, CKD, and ADPKD. We will also discuss therapeutic options and the current controversies around them.
Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
COVID-19 & The Kidneys
In this webinar, Dr. Yongen Chang discusses the currently known pathophysiology of COVID-19 and important considerations in the care of patients with kidney disease.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - Events
